ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0712

Clinical and Histologic Prognostic Factors of Renal Progression in Adults with IgA Vasculitis

Meenakshi Vanka1 and Taesoo Kim2, 1Oregon Health & Science University/Emory, Atlanta, GA, 2Oregon Health & Science University, Portland, OR

Meeting: ACR Convergence 2023

Keywords: Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0691–0721) Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: IgA Vasculitis (IgAV) is a systemic small vessel vasculitis that affects the skin, joints, gastrointestinal tract, and kidneys. While most common in children, it is rare in adults and associated with worse prognosis. IgAV has a variable course with many patients spontaneously entering remission, making it difficult to know which patients need treatment.

A few retrospective trials have shown that adult IgAV patients with greater proteinuria, kidney insufficiency at time of biopsy, and hypertension have worse overall prognosis, often developing progressive kidney disease. Retrospective studies in European and Asian populations have also considered the MEST-C renal biopsy score components as predictive tools in IgAV.

The goal of this study is to expand on existing studies and identify clinical factors that predict poor outcome in IgAV adults. We also aim to identify histologic prognostic factors using the MEST-C score components. Identifying prognostic factors will improve patient treatment plans while informing future therapeutic studies.

Methods: We conducted a retrospective analysis of 31 IgAV adult patients. A Cohort Discovery Tool was built to identify eligible patients. The primary outcome was progressive kidney disease, defined as nephrotic range proteinuria ( > 3.5g/d) or > 30% creatinine elevation within 1 year of kidney biopsy.

We included patients age > 18, with at least one symptom of IgA Vasculitis (cutaneous palpable purpura, arthritis, bowel angina), and kidney biopsy consistent with IgAV.

We collected data on patient’s kidney function at time of diagnosis, and at 3, 6, and 12 month intervals. For preliminary analyses, we assessed Pearson correlation of clinical factors and MEST-C components with the primary outcome.

Results: Baseline creatinine was shown to have significant correlation with renal progression at 1 year, yielding a Pearson coefficient of .887 (2-tailed significance < .001, n = 21). Age, systolic blood pressure, and degree of proteinuria did not have significant Pearson coefficients at 3, 6, or 12 month intervals.

The “E” component in MEST-C, which stands for Endocapillary Hypercellularity, also showed significant correlation with renal progression at 1 year, with a Pearson coefficient of .776 (2-tailed significance < .001, n = 26). Other components of the MEST-C score did not yield significant correlations

Conclusion: Similar to existing studies, renal insufficiency at baseline is a prognostic indicator of poor outcomes in IgA Vasculitis patients. Age, initial proteinuria, and hypertension were not correlated with kidney progression in our study, which diverges from prior literature. Regarding histologic predictive factors, the “E” in MEST-C (Endocapillary Hypercellularity) is predictive of renal progression in prior studies, and we were able to validate this finding. Next steps in our study include expanding our cohort, as well as correlating treatment regimens with renal progression at 1 year.


Disclosures: M. Vanka: None; T. Kim: None.

To cite this abstract in AMA style:

Vanka M, Kim T. Clinical and Histologic Prognostic Factors of Renal Progression in Adults with IgA Vasculitis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/clinical-and-histologic-prognostic-factors-of-renal-progression-in-adults-with-iga-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-and-histologic-prognostic-factors-of-renal-progression-in-adults-with-iga-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology